A Single Arm Phase II Study Evaluating the Efficacy and Safety of MEDI4736 in Combination with Tremelimumab in Patients with Metastatic HER2 Negative Breast Cancer

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.